↓ Skip to main content

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity

Overview of attention for article published in Frontiers in oncology, November 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
Published in
Frontiers in oncology, November 2021
DOI 10.3389/fonc.2021.778989
Pubmed ID
Authors

Hyeree Choi, Michelle Ho, Opeyemi S Adeniji, Leila Giron, Devivasha Bordoloi, Abhijeet J Kulkarni, Alfredo Perales Puchalt, Mohamed Abdel-Mohsen, Kar Muthumani

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 21%
Student > Ph. D. Student 3 11%
Student > Doctoral Student 2 7%
Researcher 2 7%
Student > Master 1 4%
Other 1 4%
Unknown 13 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 18%
Chemistry 4 14%
Immunology and Microbiology 3 11%
Medicine and Dentistry 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 0 0%
Unknown 14 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2021.
All research outputs
#16,059,145
of 25,392,582 outputs
Outputs from Frontiers in oncology
#5,644
of 22,436 outputs
Outputs of similar age
#265,018
of 513,634 outputs
Outputs of similar age from Frontiers in oncology
#290
of 1,365 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,634 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,365 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.